CRISPR-induced exon skipping of β-catenin reveals tumorigenic mutants driving distinct subtypes of liver cancer
H. Mou, J. Yue, Y. Jin, Z. Wang, Y. Gao, T. Janowitz, H. V. Meyer, A. Kucukural, J. E. Wilkinson, D. M. Ozata, S. Beyaz
This study shows CRISPR/Cas9 can induce exon skipping in β-catenin, creating gain-of-function mutations that drive distinct liver cancer subtypes in mice and are found in human HCC patients.
bioRxiv · Mar 27, 2022Cancer Biology